One Dose of Lilly’s Novel Heart Drug Cut Risk Factors for a Year

Paulson’s $1 Billion Caribbean Empire Faces Crisis and Betrayal

Amgen-Horizon Takeover Seen Close to a Lock After FTC Pauses Challenge

Drugmakers Eye $23 Billion Biotech Argenx Ahead of Key Data

FTC to Sue to Block Amgen’s Takeover of Horizon Therapeutics